NYSE - Delayed Quote USD

BlackRock Health Sciences Trust (BME)

39.06 +0.02 (+0.05%)
At close: April 26 at 3:59 PM EDT
Key Events
Loading Chart for BME
DELL
  • Previous Close 39.04
  • Open 39.09
  • Bid 38.20 x 800
  • Ask 39.13 x 1000
  • Day's Range 39.06 - 39.27
  • 52 Week Range 35.53 - 43.19
  • Volume 24,850
  • Avg. Volume 30,530
  • Market Cap (intraday) 544.653M
  • Beta (5Y Monthly) 0.68
  • PE Ratio (TTM) 27.12
  • EPS (TTM) 1.44
  • Earnings Date --
  • Forward Dividend & Yield 2.56 (6.54%)
  • Ex-Dividend Date Apr 12, 2024
  • 1y Target Est --

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BME

Performance Overview: BME

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BME
1.45%
S&P 500
6.92%

1-Year Return

BME
1.68%
S&P 500
25.26%

3-Year Return

BME
3.28%
S&P 500
22.00%

5-Year Return

BME
39.31%
S&P 500
74.29%

Compare To: BME

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BME

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    544.65M

  • Enterprise Value

    --

  • Trailing P/E

    27.12

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    26.68

  • Price/Book (mrq)

    0.93

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    244.30%

  • Return on Assets (ttm)

    0.21%

  • Return on Equity (ttm)

    3.37%

  • Revenue (ttm)

    8.19M

  • Net Income Avi to Common (ttm)

    20.02M

  • Diluted EPS (ttm)

    1.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    534

  • Total Debt/Equity (mrq)

    0.01%

  • Levered Free Cash Flow (ttm)

    4.66M

Company Insights: BME

People Also Watch